top of page

Carcinoma Breast- AI Simulated Case Scenario Discussions

Updated: 33 minutes ago

Infographic- Carcinoma Breast
Infographic- Carcinoma Breast

Carcinoma Breast- AI Simulated Case-Scenario Discussions


General Principles and Triple Assessment

  • The foundation of breast cancer diagnosis is the Triple Assessment protocol, which includes clinical examination, imaging, and pathological assessment.

  • Diagnostic accuracy reaches 99.9% when all three modalities of the Triple Assessment align.

  • Imaging choices are age-dependent, with ultrasound preferred for women under 35 and mammography for those over 35.

  • Core needle biopsy is superior to fine-needle aspiration because it differentiates between in situ and invasive disease and allows for hormone receptor and HER2 status testing.

  • The majority of breast cancers are sporadic, accounting for 65% to 75% of cases, while hereditary factors like BRCA 1 and 2 mutations contribute to 5% to 10%.


Classification and Clinical Presentation

  • Breast cancer is classified into non-invasive types, such as Ductal Carcinoma In Situ (DCIS), and invasive types, of which invasive ductal carcinoma is the most common.

  • The most frequent clinical presentation is a hard, irregular, non-tender, and poorly mobile palpable mass.

  • Approximately 60% of breast tumors are located in the upper outer quadrant.

  • Advanced clinical features include skin dimpling from Cooper's ligament involvement, nipple retraction, and peau d'orange due to lymphatic obstruction.

  • Paget’s disease of the nipple presents as a unilateral, eczema-like ulceration and is often associated with an underlying malignancy.


Staging and Prognosis

  • Clinical staging follows the TNM system, assessing the primary tumor size (T), regional lymph node involvement (N), and distant metastasis (M).

  • Stage I and II are classified as early breast cancer, Stage III as locally advanced, and Stage IV as metastatic disease.

  • The Nottingham Prognostic Index (NPI) calculates prognosis based on tumor size, nodal status, and histological grade.

  • Five-year survival rates decrease significantly with advancing stage, from 90% in Stage I to 20% in Stage IV.


Management of DCIS and Early Breast Cancer (Stages I & II)

  • DCIS is a non-invasive cancer confined by an intact basement membrane that requires treatment to prevent progression to invasive disease.

  • Standard treatment for DCIS is breast-conserving surgery (BCS) followed by radiation, or a mastectomy if the disease is widespread.

  • For early invasive cancer, BCS followed by radiation is oncologically equivalent to a total mastectomy.

  • Sentinel lymph node biopsy (SLNB) is the standard for staging the axilla in clinically node-negative patients to avoid the morbidity of full axillary dissection.

  • Adjuvant systemic therapy, including endocrine therapy for ER-positive tumors and anti-HER2 therapy for HER2-positive tumors, is dictated by the tumor's biological profile.


Management of Locally Advanced (Stage III) and Metastatic Cancer (Stage IV)

  • Locally advanced breast cancer is treated with neoadjuvant systemic therapy as the first step to shrink the tumor and treat micrometastatic disease before surgery.

  • Following neoadjuvant therapy, axillary lymph node dissection is mandatory if nodes were positive at presentation, regardless of the clinical response.

  • Post-mastectomy radiation is indicated for tumors larger than 5 cm or when four or more axillary nodes are positive.

  • Metastatic (Stage IV) disease is treatable but generally incurable, focusing on palliation and maintaining quality of life.

  • Systemic therapy is the mainstay for Stage IV, and routine surgery on the primary tumor is avoided unless needed for local symptom control.

  • Bone is the most common site of metastasis, requiring management with bone-modifying agents like bisphosphonates to prevent skeletal complications.


For visual learners, please watch the AI-simulated case discussion video on Carcinoma Breast- AI Simulated Case Scenario Discussions from my YouTube video embedded below.



For visual learners, please watch the AI-simulated case discussion video on Carcinoma Breast- AI Simulated Case Scenario Discussions in Tamil Language from my YouTube video embedded below.




Listen to my Apple Audio podcast on Carcinoma Breast- AI Simulated Case Scenario Discussions with earphones for an immersive and transformational Learning Experience, especially for auditory learners.



Download the following Word document to learn 10 useful MCQs + 5 Clinical Pearls + 5 Clinical Pitfalls on Carcinoma Breast- AI Simulated Case Scenario Discussions



 
 
 

Comments


bottom of page